Company Filing History:

13 out of 129

Dainippon Pharmaceutical Company, Limited

patents

2 out of 19

Laboratoire Roger Bellon

patents

1 out of 2

Laboratorie Roger Bellon

patents

where one patent can have more than one assignee

Years Active: 1976-1992

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5164392 - Quinoline derivatives and antibacterial agent containing them (1992-11-17),

2. 5051419 - Prevention or elimination of mycoplasma contamination of animal or plant (1991-09-24),

3. 5013841 - Oxo quinoline derivatives (1991-05-07),

4. 4886810 - Quinoline derivatives, pharmaceutical composition and method of use (1989-12-12),

5. 4795751 - 5-substituted-6,8-difluoroquinolines useful as antibacterial agents (1989-01-03),

6. 4738968 - 1,8-naphthyridine derivatives useful as anti-bacterial agents (1988-04-19),

7. 4649144 - Antibacterial (1987-03-10),

8. 4545932 - Glucosaminyl muramyl peptide derivatives (1985-10-08),

9. 4497816 - 7-(4-Pyridyl)-1,8-naphthyridine derivatives and their antibacterial (1985-02-05),

10. 4496566 - Naphthyridine derivatives (1985-01-29),

11. 4382937 - Naphthyridine derivatives and their use as anti-bacterials (1983-05-10),

12. 4017622 - Piperazine derivatives (1977-04-12),

13. 3962443 - Antibacterial pharmaceutical compositions and processes for preparation (1976-06-08),

Title: The Innovative Contributions of Shinichi Nakamura

Introduction

Shinichi Nakamura is a prominent inventor based in Takatsuki, Japan. He has made significant contributions to the field of antibacterial agents, holding a total of 13 patents. His work focuses on developing compounds that exhibit excellent antibacterial activity, which are crucial in various applications.

Latest Patents

Among his latest patents is a quinoline derivative that demonstrates remarkable antibacterial properties. This compound is characterized by a specific formula where Z is an amino group or a halogen atom, and R1, R2, and R3 can be hydrogen or lower alkyl groups with 1 to 5 carbon atoms. Additionally, he has developed a method for preventing or eliminating mycoplasma contamination in animal or plant cell cultures. This method involves adding an effective amount of a specific quinoline compound to the culture medium, showcasing his innovative approach to addressing contamination issues.

Career Highlights

Shinichi Nakamura has worked with notable companies, including Dainippon Pharmaceutical Company, Limited and Laboratoire Roger Bellon. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in antibacterial research.

Collaborations

Throughout his career, Nakamura has collaborated with esteemed colleagues such as Jun-ichi Matsumoto and Yoshiyuki Takase. These partnerships have fostered a collaborative environment that has led to groundbreaking discoveries in the field of antibacterial agents.

Conclusion

Shinichi Nakamura's contributions to antibacterial research and his innovative patents highlight his importance in the scientific community. His work continues to influence the development of effective antibacterial agents, showcasing the impact of his inventions on public health.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.